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1. Introduction
Tuberculosis (TB) is an old infectious disease that has affected humans for millennia [1]. This
disease is caused by infection with bacilli belonging to the Mycobacterium tuberculosis (Mtb)
complex and is responsible for 1.3 million deaths around the world, making TB the second
leading cause of death by infectious disease caused by a single pathogen. In addition to this
high number of deaths, a large proportion of individuals present latent TB infection (LTBI): it
is estimated that at least one third of the human population could have LTBI [2]. Why more
than 90% of the individuals infected with Mtb do not develop the active form of the disease is
unclear, although the immune status of the individual seems to play a crucial role for Mtb
containment [3]. This is evident in individuals with Human Immunodeficiency Virus co-
infection, who are more prone to develop active TB: a quarter of TB deaths occur in individuals
co-infected with HIV [2].
However, other factors are associated with TB development, such as the host environment and
the genetic diversity of Mtb. This genetic diversity has been organized into genotypes and
lineages, according to the genetic profiles obtained by techniques such as IS6110 fingerprinting,
spoligotyping and mycobacterial interspersed repetitive units-variable number of tandem
repeats (MIRU-VNTR). Interestingly, these genotypes show a differential distribution around
the world and exhibit different levels of virulence [4]. One of the genotypes that has attracted
more attention in recent years is the Beijing family, because it is highly prevalent among TB
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patients, it favours the spread of multidrug-resistant tuberculosis, and it has been suggested
that BCG vaccination confers poor protection against it [5].
It is not clear why the Beijing genotype prevails in infected individuals. One factor that could
be responsible for this phenomenon is the interaction that Mtb Beijing establishes with the
immune response. In this chapter, we analyze and discuss current knowledge regarding the
cellular and molecular mechanisms of the immune response to Mtb, and how these mecha‐
nisms are affected by the Beijing genotype in relation to human infections.
2. Immune response to Mycobacterium tuberculosis
Mtb can enter the body through several routes, but the most usual one is through the airways
[6]. This process is initiated by the release of small saliva droplets containing Mtb bacilli that
are expelled by active TB patients [7]. Some droplets are small enough to cross the mucociliary
barrier and reach the alveoli, where they interact with the first cellular element of the immune
response, the alveolar macrophage [8]. Macrophages are armed with a vast array of innate
immune receptors that allow direct recognition of Mtb; these receptors include Toll-like
receptors (TLR), Nod-like receptors (NLR), C-type lectin receptors (CLR) and scavenger
receptors [9]. After recognition, macrophages ingest bacilli by phagocytosis, but they are
unable to kill them due to the evolutionary mechanisms acquired by Mtb that actively inhibit
phagosome maturation and protect Mtb from destruction by toxic compounds, such as reactive
nitrogen and oxygen intermediates and hydrolytic enzymes from lysosomes; these mecha‐
nisms allow intracellular Mtb survival and proliferation [10, 11].
In addition to this intracellular proliferation, Mtb also induces a strong inflammatory response,
characterized by macrophage production of cytokines like TNF-α, IL-1β and IL-6, which
promote the recruitment of more macrophages from the blood [12]. The recruited macrophages
are able to ingest bacilli but, like alveolar macrophages, they are unable to eliminate the
ingested Mtb. The continuous recruitment of macrophages during these early stages provides
a constant supply of cells susceptible to infection, as well as an increase of inflammatory signals
that induces the recruitment of more susceptible cells from the blood, without causing
significant tissue damage. At the same time, lung resident dendritic cells (DCs) engulf bacilli
or their derived products; the inflammatory environment promotes DCs migration from the
lungs to the draining lymph nodes, where they activate Mtb antigen-specific naïve T cells and
induce a strong T cell response characterized by proliferation and activation of Mtb antigen-
specific CD4+and CD8+T cells [13]. These T cells travel through the blood and are recruited to
the infection site by the ongoing inflammatory process.
Upon recognition of the infected macrophages, T cells produce significant amounts of TNF-
α and IFN-γ, the cytokines that characterize a Th1 response. TNF-α and IFN-γ increase the
microbicidal mechanisms of the infected macrophages, which eventually leads to the intra‐
cellular killing of Mtb. Macrophage activation can be limited by the secretion of IL-4, IL-10 and
TGF-β produced by Th2 and T regulatory (Treg) cells [14-16]. The Th1 response, however, does
not lead to a complete elimination of Mtb, but to the formation of an organized cellular
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structure, the granuloma, where live mycobacteria persist in a dormant state known as latent
infection [17]. The structure of the granuloma varies, but usually its center is formed by caseum,
a structure that contains abundant remains of dead cells and forms a hypoxic, acidic and lipid-
rich environment that limits extracellular Mtb proliferation. The caseum is limited by highly
activated macrophages (multinucleated Langhans cells and foamy macrophages) surrounded
by CD4+and CD8+T cells [18]. While the host immune response is unaffected, the granuloma
structure is preserved and Mtb is contained within; however, the alteration of crucial elements
of the immune response, such as the decrease of CD4+T cells during HIV infection or the
blockade of TNF-α by therapeutic antibodies, causes disorganization of the granuloma
structure, caseum liquefaction and oxygen access, which promotes Mtb extracellular prolifer‐
ation and dissemination into the airways, from where Mtb can reach susceptible hosts [19-21]
(Figure 1).
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Figure 1. Development of the immune response to Mycobacterium tuberculosis. The main four stages of the immune
response to Mycobacterium tuberculosis (Mtb) are depicted. Macrophages are the first component of the cellular immune
response that is encountered by Mtb (top left); they are used by Mtb to replicate and to induce an inflammatory re‐
sponse that allows the recruitment of more macrophages susceptible to infection. Dendritic cells (top right) carry Mtb
antigens from the infection site to the draining lymph nodes, to activate antigen-specific T cells. The mycobacterial
granuloma (bottom right) plays a fundamental role in Mtb containment. Alterations in the dynamic equilibrium of the
granuloma (bottom left) promote disorganization and access of extracellular Mtb to oxygen, which allows its replica‐
tion and dissemination through the airways.
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3. Mycobacterium tuberculosis Beijing genotype
Because Mtb strains present over 99 % of similarity at their nucleotide sequence level and have
identical sequences of their 16S RNAs [22, 23], for several years it was thought that they were
genetically homogeneous and lacked genetic diversity. However, the development and use of
different genetic tools for the study of Mtb revealed greater diversity. Studies that analyzed
repetitive DNA elements in Mtb led to the discovery of high polymorphism in several strains.
The study of restriction fragment length polymorphism (RFLP) in IS6110 allowed van
Soolingen et al to identify a group of strains, isolated in Beijing, Mongolia, South Korea and
Thailand, which shared a unique RFLP pattern. Since the majority of these strains came from
Beijing, they became known as the “Beijing family”. Further genetic characterization showed
that all these strains shared an identical spoligotyping of the direct repeat (DR) region, and
similar patterns of polymorphic GC-rich sequence (PGRS) as well as an IS1081 restriction
fragments [24]. Mtb strains with these genetic characteristics were later found outside the
Southeast Asian region, in Russia, Spain, the United States, Cuba, Peru, Colombia, Iran, Israel
and South Africa [5, 25].
Beijing strains were classified as “typical”, if they presented one or more IS6110 insertions in
the noise transfer function (NTF) region, or “atypical”, if they lacked this insertion [26, 27].
Analysis of large sequence polymorphisms (LSP) indicated that Beijing strains could be
divided into four different lineages, depending on the presence of RD105, RD142, RD150 and
RD181 [28]. Further studies, using PCR to analyze 40 different loci in Beijing strains, showed
that this group could also be divided into seven different sub-lineages, thus revealing great
genetic diversity in this group [29].
4. Clinical importance of Mycobacterium tuberculosis Beijing genotype
In addition to the high prevalence of Beijing strains in the Southeast Asian region, Beijing
strains have been associated with outbreaks in different parts of the world. The strains that
were responsible for a TB outbreak in New York in the 1990’s were from the Beijing genotype,
and they were more frequent in patients co-infected with HIV, reaching a mortality rate of
more than 80%. Interestingly, strains from this outbreak had multidrug resistance to isoniazid,
rifampicin, streptomycin, ethambutol, ethionamide, rifabutin and kanamycin, favouring
treatment failure [30-32]. Later studies showed the global emergence of this genotype in
different parts of the world [25, 33, 34].
Several epidemiological studies have documented the hyper-virulence of the Beijing genotype.
For example, patients infected with Beijing strains have increased rates of treatment failure
and relapse [35-39]. In line with these studies, Kong et al showed that patients infected with
Beijing strains developed more extra-thoracic TB than patients infected with other genotypes
[40]. Other studies demonstrated that individuals infected with strains from the Beijing
genotype were more likely to progress to active TB [41, 42] and had increased drug resistance
[43, 44]. Furthermore, patients infected with these strains were younger than patients infected
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with other genotypes [45], and they developed febrile responses in earlier stages of treatment
[46]. Moreover, infection with Beijing strains was associated with HIV co-infection [47] and
BCG vaccination [48]. However, others have been unable to find an association between
infection with Beijing strains and the aforementioned clinical manifestations of the disease [38,
45, 49-54].
Few studies focused on the immune response have been conducted in patients infected with
Beijing strains. Sun et al found that the sera of patients infected with Beijing and non-Beijing
strains had similar levels of IFN-γ and IL-18, while peripheral blood mononuclear cells
(PBMCs) expressed similar mRNA levels for IFN-γ, IL-2, IL-18. However, patients infected
with Beijing strains had decreased levels of IL-4 [55]. In contrast with these results, Rakotosa‐
mimanana et al observed that PBMCs from patients infected with the “modern” Mtb strains
from Beijing and Central Asia produced less IFN-γ in response to ESAT-6 than PBMCs from
patients infected with other genotypes [56]. These results suggest that Mtb Beijing genotype
could induce an altered immune response that could favor infection by these strains.
5. Effects of Mycobacterium tuberculosis Beijing genotype on the immune
response: in vivo models
The first evidence of the hyper-virulence of the Mtb Beijing genotype came from studies with
different mouse models of infection. Manca et al showed that the Beijing strain HN878, isolated
from cases from an outbreak in Texas, led to higher bacterial loads in the lungs and to
accelerated death in immune-competent mice, compared to a non-Beijing strain. Moreover,
the lymph node and spleen cells from HN878-infected mice showed decreased proliferation
and IFN-γ production after in vitro re-stimulation, suggesting a defective induction of a Th1
response because of the early induction of type I IFN by HN878 [57, 58]. Later studies showed
that the decrease in the Th1 response was associated with the induction of Treg cells in mice
and also in guinea pigs, an animal model that resembles human tuberculosis [59, 60]. Intra‐
cisternal infection of rabbits with Mtb leads to the development of tuberculous meningitis. In
this model of infection, the Beijing strains HN878 and W4 led to higher bacterial loads in the
cerebrospinal fluid and brain, increased dissemination to the lungs and liver, earlier leukocy‐
tosis, increased levels of TNF-α during the later stages of the infection, and severe clinical
manifestations, compared to the low-virulence strain CDC1551 [61].
López et al reported that three Beijing strains, representing the predominant genotypes in Asia,
were hyper-virulent in a mouse model of progressive pulmonary tuberculosis, compared to
other genotypes (Somali, Haarlem, Canetti and H37Rv). This hyper-virulence was reflected as
an increased number of bacteria in the lungs and a rapid death of the mice infected with the
Beijing strains. The mice infected with the Beijing strains had altered immune responses: they
expressed TNF-α and iNOS in their lungs during the early stages of the disease, but had a
defective production of iNOS and IFN-γ during the later stages of the infection [62]. Further
studies associated this phenomenon with a decrease in Th1 cells caused by apoptosis and with
a defective cytotoxicity, indicative of a deficient CD8+T cell response [63, 64]. A more recent
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report with the Beijing strain K1, isolated in Korea, showed that this strain is hyper-virulent,
and the lungs of infected mice had a decreased production of Th1 and Th2 cytokines [65]. The
hyper-virulence of the Beijing strains was also observed when they were compared to East
African-Indian strains in mice [66].
However, Dormans et al showed that hyper-virulence is not associated with all the Beijing
strains. He observed that strain 9402008, isolated from Asia, caused little lung pathology,
bacterial load and mortality in mice [67]. Furthermore, Aguilar et al showed that Beijing strains
isolated in South Africa, which presented low transmissibility in humans, were less virulent
than the Beijing strains that were highly transmissible [68]. The highly transmissible Beijing
strains caused an early induction of TNF-α and delayed IL-4 production, as well as defective
induction of IFN-γ and iNOS in the lungs during the later stages of the disease, compared to
the low-virulence Beijing strains [68]. This difference in virulence among Beijing strains was
also observed in a mouse model of infection with seven Beijing strains isolated in Vietnam [69],
and in guinea pigs infected with ten Beijing strains isolated in the USA. Interestingly, the lungs
of these guinea pigs also showed differential patterns of T cell infiltration and cytokine
production: virulent strains induced less IFN-γ during the later stages of the infection,
compared to low-virulence strains [70]. A more recent study showed that heterogeneity in
virulence was also observed in mice infected with Beijing strains isolated from Brazil and
Mozambique [71].
From these in vivo experiments, it is clear that hyper-virulence is not a unique characteristic
that applies to all the strains from the Beijing genotype. However, all the hyper-virulent strains
from the Beijing group share a common characteristic: they are able to interfere with the Th1
response that is crucial for infection containment, favoring the dissemination of bacilli in the
lung and an increased pathology.
6. Effects of Mycobacterium tuberculosis Beijing genotype on the immune
response: in vitro models
6.1. Macrophages
Several studies have analyzed the ability of the Beijing strains to replicate inside macrophages
and to induce cytokine production by these cells. One of the first studies that showed a
differential response of macrophages to the Beijing strains was performed in human macro‐
phages. The Beijing strain 210, isolated in the USA, grew faster in human macrophages than
other Mtb strains tested, but there were no differences among the strains regarding the
induction of TNF-α, IL-6, IL-10 or IL-12 [72]. A faster intracellular replication of the bacilli in
human macrophages was also observed with four different Beijing strains [73]. In contrast with
these results, Manca et al showed that human monocytes infected with the Beijing strain HN878
produced increased mRNA levels for IL-4, IL-11, IL-13, type I IFN, TRAIL and VEGF, com‐
pared to monocytes infected with the low-virulence strain CDC1551 [74], and our group
reported that the hyper-virulent Beijing strain 9501000 induced higher expression of IL-1β,
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TNF-α and IL-12 in mouse bone marrow-derived macrophages (mBMDM), in comparison to
a low-virulence strain of the Canetti genotype [75].
Theus  et  al  used  fifteen  different  strains  of  the  Beijing  genotype  and  infected  IFN-γ-
activated  THP-1  cells  (a  human  monocyte-like  cell  line);  interestingly,  they  observed  a
spectrum of growth and TNF-α induction among these Beijing strains [76]. Tanveer et al
observed that ten Beijing strains induced similar levels of TNF-α in PMA-stimulated THP-1
cells  than  Central  Asian  strains,  but  lower  levels  of  TNF-α  than  H37Rv  [77].  A  low
production of TNF-α, IL-6, IL-10 and CXCL1 was also observed in monocyte-derived human
macrophages infected with nine different Beijing strains, compared to macrophages infected
with H37Rv [78]. In line with this study, Reiling et al  reported that human macrophages
stimulated with four Beijing strains produced lower levels of TNF-α, IL-1β, IL-6, IL-12 and
CCL5 than Haarlem strains  [66],  and Portevin  et  al  extended this  observation to  “mod‐
ern” Mtb lineages, including Beijing genotype strains [79]. However, Krishnan et al observed
that seven Beijing strains induced higher IL-1β and TNF-α production than Euro-Ameri‐
can strains, but there was considerable heterogeneity in the amount of cytokines induced
by  each  Beijing  strain  [69].  Heterogeneity  in  the  amount  of  IL-1β  produced  was  also
observed in mBMDM infected with seven Beijing strains [80].
Altogether, these results point to a heterogenic response of macrophages to different isolates
of the Beijing genotype. Besides the obvious differences in the biological systems used in the
studies summarized in the previous paragraphs, which could explain the differing results,
experiments that have used the same in vitro model show that the induction of heterogenic
cytokine responses is a common characteristic of the Beijing genotype. Two patterns are
observed: one is characterized by low induction of pro-inflammatory cytokines, which is
associated with a poor regulation of intracellular bacterial replication. The second pattern is
characterized by a higher production of pro-inflammatory cytokines, and in vivo evidence
indicates that, during the early stages of an infection with these strains, there is an inflamma‐
tory response of equal or higher magnitude than the inflammatory response induced by other
genotypes. This, however, raises a question: how could high levels of pro-inflammatory
cytokines be favorable to the pathogen? The paradox may be explained by the function that
these cytokines play during Mtb infection. For instance, macrophage-produced TNF-α is
associated with macrophage self-activation and control of the intracellular replication of Mtb
during the early stages of the infection but, according to a mouse model of infection, it is the
T cell-produced TNF-α that is essential for mycobacterial containment during the chronic
infection [81]. The recruitment of macrophages with low anti-mycobacterial capacity during
the early stages actually favors infection dissemination [82], so the induction of an inflamma‐
tory environment that allows the recruitment of such cells could be actively pursued by some
virulent Mtb strains.
6.2. Dendritic cells
Although DCs play a crucial role for the mounting of T cell responses to Mtb, few studies have
analyzed how Beijing strains affect DC functions. The first studies on this subject analyzed
cytokine production by DCs. Wang et al observed that human derived DCs stimulated with
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Beijing strains produced low levels of TNF-α, IL-6 and CCL3, compared to DCs stimulated
with H37Rv [78]. Portevin et al observed that human DCs stimulated with “modern” Mtb
lineages, which include Beijing genotype strains, produced less pro-inflammatory cytokines
than DCs stimulated with “ancient” Mtb lineages [79], while Krishnan et al did not observe
any difference in cytokine production by mouse bone marrow derived DCs (mBMDDCs)
stimulated with Beijing strains, H37Rv or other genotypes [69]. Recently, our group reported
that a hyper-virulent Beijing strain failed to activate mBMDDCs (assessed by MHC class II
expression) but did not affect the induction of CCR7 expression, which is essential to drive DC
migration from the tissues to the lymph nodes. Moreover, these DCs had higher levels of PDL-1
and IL-10 than DCs stimulated with low-virulence strains. Interestingly, the phenotypic
changes correlated with alterations in DC function, as revealed by their inability to induce a
Th1 response [83]; a phenomenon usually observed during in vivo infections with hyper-
virulent Beijing strains.
6.3. Human peripheral blood mononuclear cells
Human PBMCs consist mainly of monocytes, T cells, B cells and NK cells. Assays where PBMCs
are stimulated with pathogens or their antigens can be used to evince T cell-mediated immune
responses [84]. In one of the first studies that used PBMCs to assess granuloma formation in
vitro, the authors analyzed two Beijing strains and did not observe a difference in the number
or size of the granulomas induced by these strains, compared to the granulomas induced by
Haarlem, Latin American-Mediterranean or East African-Indian strains [78]. Our group
reported that the PBMCs from healthy BCG-vaccinated individuals stimulated with Beijing
strains presented CD4+and CD8+T cell proliferation responses similar to those induced by the
less virulent Canetti and H37Rv strains, and that the Beijing strains induced higher production
of IL-10 and IL-12, but similar levels of IFN-γ [85]. Recently, van Laarhoven et al analyzed the
effect of fourteen Beijing strains on cytokine production by PBMCs from non-BCG-vaccinated
healthy individuals; “modern” Beijing strains induced lower levels of IL-1β, IFN-γ and IL-22
than “ancient” Beijing strains [86]. In contrast, Portevin et al did not observe a difference in
cytokine production by PBMCs stimulated with several Beijing strains [79]. One explanation
for the different response of PBMC’s, beyond the genetic diversity of Beijing strains, is the
immune status of the donors: only one study analyzed the response of BCG vaccinated
individuals, and BCG vaccination has been associated with increased susceptibility to infection
with Beijing strains [48].
The studies described above show that Beijing strains modulate the response of different cell
populations that participate during the immune response to this pathogen. However, most of
these studies are focused on macrophages, leaving aside other cell populations that are known
to participate in the immune response to mycobacteria, such as pneumocytes, neutrophils,
mast cells, NK, NKT cells, γδ T cells, B cells, etc. Studying how these cells respond to Beijing
strains will help to understand the mechanism used by this Mtb genotype to override the
immune response.
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7. Components of Mycobacterium tuberculosis Beijing genotype that
modulate the immune response
7.1. Lipids
Several Mtb components are associated with evasion of the immune response. Among them,
lipids have been widely studied, mainly because of the atypical structure of the mycobacterial
cell wall and the predominance of some types of lipids in this cell wall. Lipid extracts from the
Beijing strain HN878 induced higher expression of IL-13, G-CSF and VEGF in human macro‐
phages, compared to the expression induced by lipids from the CDC1551 strain [74]. The cell
wall lipids from hyper-virulent Beijing strain 9501000 also induced higher expression of TNF-
α and IL-10 than the cell wall lipids from H37Rv and Canetti genotype [87].
Reed et al showed that three hyper-virulent Beijing strains expressed a phenolic glycolipid
(PGL) that was not expressed by the lower-virulence strains H37Rv and CDC1551. When the
HN878 strain lost the expression of this PGL, its hyper-virulence in mice and rabbits was
diminished, and the cytokine pattern that it induced in macrophages became similar to that
induced by H37Rv [88]. Later studies showed that 102 Beijing strains had unaltered pks15/1,
the open reading frame (ORF) coding for the enzyme responsible for PGL production [28].
However, the presence of intact pks15/1 is not exclusive of the Beijing genotype [89], and some
Beijing strains that express this ORF do not produce PGL [90]. In addition, a study reported
that induction of PGL production by non-Beijing strains did not increase their virulence [91].
Regarding other lipids, Reed et al observed that 36 Beijing strains, but not Indo-Oceanic or
Euro-American strains, uniformly expressed triacylglycerides [90]. Huet et al showed that
Beijing strains presented a pattern of phthiocerol dimycoceroserates (PDIM) different to that
of other Mtb strains; this difference was associated with the mutation Rv2952G526A in the Beijing
strains, but it was not associated with the virulence of these Beijing strains [92]. Another study
reported that total lipids extracts from Beijing strains induced higher TNF-α production by
mBMDM than total lipids extracts from Euro-American strains. These Beijing strains had a
characteristic pattern of PDIM, which was different to that of other Mtb strains [69].
These studies indicate that lipids from Mtb Beijing play an important role in the regulation of
macrophage activation and in the induction of cytokine production. However, further studies
are needed to clarify how these lipids impact other arms of the immune response that are
crucial for infection containment, such as DCs and T cells specific for Mtb lipid antigens [93].
Another potential role for the lipids of the Beijing strains could be as carbon and energy
reservoirs, which would be valuable in the harsh conditions that the bacilli find inside
macrophages or in the anoxic granulomas [90].
7.2. Proteins
One of the first studies that analyzed proteins identified that a Beijing strain, but not Canetti
or H37Rv strains, expressed mRNA for PE_PGRS Rv3652 [94]. Wu et al observed that the
Beijing strain 210 had higher SigA mRNA levels than H37Rv, and that blockade of SigA
expression attenuated bacterial growth in human macrophages and in the lungs of infected
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mice, a phenomenon that was associated with increased Mtb susceptibility to reactive oxygen
intermediates [95]. Later studies showed that SigA induced up-regulation of Eis, which in turn
promoted TNF-α and IL-10 production by macrophages [96, 97].
Pheiffer et al, using proteomic techniques, found that a Beijing strain expressed higher levels
of α-crystallin and lower levels of Hsp65, PstS1 and 47kDa protein than H37Rv [98]. Interest‐
ingly, Reed et al found that Beijing strains constitutively expressed high mRNA levels of genes
in the DosR regulon, including dosR, Rv3130c, hspX, fdxA and narX; the levels of these mRNAs
were up to 50 times higher than the levels found in non-Beijing strains [90]. Usually, Mtb
induces the expression of the DosR regulon under two conditions: 1) in the lungs of infected
mice and in artificial granulomas [99], and 2) inside macrophages that are activated with IFN-
γ [100]. In consequence, the authors hypothesized that a constitutive high expression of the
genes in the DosR regulon would allow a fast adaptation of Mtb to this harsh conditions leading
to Mtb survival. The mechanisms that maintain this high expression of the DosR regulon are
unknown, but mutations in DosT sensor kinase and chromosomal duplication have been
implicated in this phenomenon [101, 102].
Rindi et al found that Beijing strains expressed high levels of PPE44, a member of the Mtb PPE
proteins that are related with antigenic variation [103]. Another approach, using proteomic
analysis among several Beijing strains with different virulence, showed that the virulent strains
over-expressed 53 proteins involved in regulation, cell wall synthesis and cell processes [104].
Recent reports indicate that the virulent Beijing strain K1 expressed higher levels of ESAT-6,
HSP-X and CFP-10 than strains from other genotypes, and it also expressed InsB, a protein
which shares homology with ESAT-6 [105, 106].
Altogether, these results indicate that Beijing strains express a different set of proteins that
could participate in many stages of the infection. First, they could modify the innate immune
response through a differential engagement of pattern recognition receptors (PRRs), inducing
a response that would favors infection [107]. Second, they could facilitate a rapid adaptation
of the bacilli to the adverse conditions found during infection (hypoxic, or rich in reactive
nitrogen and oxygen intermediates, for example) [90]. Third, the regulation of the expression
of proteins that are recognized by the adaptive immune response could facilitate immune
evasion and fostering survival of the bacteria [98].
7.3. Other molecules
Carbohydrates from Beijing strains have been poorly analyzed. Usually, carbohydrates are
associated with lipids or proteins, and they are abundant on bacterial cell walls. Carbohydrates
play a crucial role in the recognition of microbes by innate immune cells through PRRs, and
consequently, they could modulate the whole immune response to the bacilli [108, 109].
As we have seen, the immune response is crucial role for infection containment, but other non-
immune factors contribute to Mtb virulence, and a conjunction of all these factors defines the
outcome of the infection. Metabolomic studies of hyper-virulent and hypo-virulent Beijing
strains have reported a difference in the presence of different metabolites, including amino
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acids, carbohydrates and lipids [110]. How this difference impacts bacterial phenotype needs
further clarification.
8. Evolution as a driving force in the success of Mycobacterium
tuberculosis Beijing genotype
The studies cited above highlight a great variation in the responses to infection with Beijing
strains, both in vivo and in vitro. One explanation for this variation could be the genetic diversity
of the Beijing strains, but some studies have been unable to correlate the different responses
with the genetic diversity of the Beijing genotype [111, 112]. So, how can we understand this
variation? Evolution has played a fundamental role in shaping the actual scenario of TB on
earth. Humans have co-existed with Mtb since our appearance as a species on this planet, and
Mtb accompanied humans since the first migrations from Africa to other parts of the world [1,
113]. These migrations and settlings allowed a co-evolution of each human population with
its pathogens, including Mtb, and this is reflected in the distribution of Mtb diversity: six
different Mtb lineages are stably associated with specific human populations, according to
their geographic distribution [4]. Mtb lineages are so well adapted to their hosts that even in
cosmopolitan areas, where diverse human populations from different geographic origins
coexist, a specific Mtb lineage preferentially infects individuals from a specific geographic
origin (sympatric transmission) [114]. Allopatric human transmission of Mtb occurs, but
infection of individuals from one geographic origin with Mtb from a different lineage is usually
associated with other factors, such as HIV co-infection. Patients with allopatric infections have
increased pulmonary impairment, compared to patients with sympatric infections [114, 115].
Mtb Beijing genotype belongs to the East-Asian lineage, and it is strongly associated with hosts
from this geographic area. When Mtb Beijing genotype is introduced to new areas, where it is
uncommon, it preferentially infects hosts that also come from its original geographic area.
Studies in Italy and Sweden indicate that infection with Mtb Beijing genotype is uncommon
among natives and more frequent among migrants from areas commonly infected by this
genotype, which suggests a poor adaptation of Mtb Beijing genotype to the native hosts [116,
117]. In fact, the genetic diversification of Mtb Beijing genotype has been associated with
adaptation to particular human populations [118].
Which host factors predispose to infection with Mtb Beijing genotype? Some studies indicate
that infection with Beijing strains occurs preferentially in hosts that have particular polymor‐
phisms in immune response genes. In Vietnamese patients, infection with Beijing strains was
associated with the presence of the TLR-2 allele T597C [119], and recent reports indicate that
TLR-2 polymorphisms are differentially distributed in human populations according to their
geographic localization and ethnicity [120]. Whether these polymorphisms affect the immune
response to Beijing strains still needs to be analyzed, but differential activation of TLR-2 and
TLR-4 by Mtb strains from different genotypes has an impact on the immune response to the
bacilli [121].
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Crevel et al found that, in Indonesian patients, the polymorphism D453N G and an insertion
in the 3’untranslated region (UTR) of the slc11a1 gene (formerly known as nramp1) were
strongly associated with Beijing strains infection [122]; polymorphisms in this gene (which
codes for an iron transporter in macrophages) have been associated with TB susceptibility
[123]. Salie et al documented an association between MHC class I alleles and infection with
Beijing strains in South Africans, where the allele B*07:05 increased the odds of infection with
Beijing strains, while the allele B*35:01 had the opposite effect. Interestingly, B*07:05 is a
frequent allele in East Asian populations [124]. MHC class I molecules are essential for antigen
presentation to CD8+T cells, which are needed for the containment of Mtb infection [125]. These
studies provide evidence of a co-evolution between Beijing strains and their hosts.
9. Conclusion
Mtb Beijing genotype has attracted attention because of its high prevalence among TB patients,
but despite multiple studies, the causes of this success remain obscure. An interesting aspect
of Mtb Beijing genotype infection is the diversity of the immune responses that are induced in
humans and in experimental models (in vivo and in vitro). It is possible that this diversity results
from the adaptation of Mtb Beijing genotype to the genetic background of its hosts and to other
evolutionary pressures, such as drug treatment, BCG vaccination and HIV co-infection. These
factors, and others still unknown, will shape the strategies used by Beijing strains to override
the immune response and to establish successful infections in the host.
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